Sanders Morris Harris

- Jerini was founded in 1994 as a spin-off from the Medical Faculty (Charité) Humboldt University Berlin to commercialize the SPOT™ technology. The evolving SPOT™ platform was marketed as fee for service projects to pharmaceutical and biotech companies (1995 to 1999). The revenues generated supported the expansion of the company and its technology development. At this stage no venture capital was raised. Due to the expanding applications of its technology platform in drug discovery and proteomics Jerini began its transformation into a drug discovery company. - To support and accelerate the drug discovery transition Jerini raised Euro 4.6 million in January 2000 in a first financing round that included local investors IBB-Bet. GmbH, bmp AG and tbg. In 2001 the company converted to an AG (joint-stock company) and closed its second, private financing round raising Euro 20 million in November 2001. The investors in this round included an international group represented by TVM, 3i, Polytechnos and Sanders Morris and Harris. - In 2000 Jerini started creating the medicinal chemistry platform PepMed™ focusing on the identification of peptide lead structures addressing difficult protein targets and their subsequent systematic transformation into drug-like molecules. - In December 2001 Jerini started its first clinical trials with Icatibant, a peptidomimetic bradykinin receptor antagonist for the indication defined as end-stage liver cirrhosis.

Lombardi Software, Inc. provides a suite of business process management (BPM) software and services in the United States. Its products include Teamworks 6, a BPM software suite that offers a platform to deliver applications that support process improvement; and Blueprint, a software-as-a-service-based BPM product for companies to map business processes, identify problems, and prioritize improvement opportunities, as well as provides process documentation and workflow diagramming tools. The company also offers process definition and deployment solutions, on-demand assistance, and education services, as well as on-site services, including mapping, modeling analysis and optimization, process design and development, project management, and SOA integration solution reviews. Its customers include financial services, government, healthcare, insurance, life sciences, manufacturing, retail, and telecommunications industries. The company was founded in 1999 and is headquartered in Austin, Texas.

Lombardi Software, Inc. provides a suite of business process management (BPM) software and services in the United States. Its products include Teamworks 6, a BPM software suite that offers a platform to deliver applications that support process improvement; and Blueprint, a software-as-a-service-based BPM product for companies to map business processes, identify problems, and prioritize improvement opportunities, as well as provides process documentation and workflow diagramming tools. The company also offers process definition and deployment solutions, on-demand assistance, and education services, as well as on-site services, including mapping, modeling analysis and optimization, process design and development, project management, and SOA integration solution reviews. Its customers include financial services, government, healthcare, insurance, life sciences, manufacturing, retail, and telecommunications industries. The company was founded in 1999 and is headquartered in Austin, Texas.

IndX Software is an enterprise software company that designs and markets operations intelligence solutions for Fortune 2000 businesses (i.e., primarily process manufacturing) and their supply chains. The company’s product, XHQ, provides a single, coherent view of information that users need for real-time decision support or performance management, by extracting and integrating data from multiple, disparate back-end systems, aggregating and managing content, and distributing information to users. In 1999, Marwit led a $10 million equity investment in the Company.

DIREVO provides customized solutions for various industries via the development and optimization of biocatalysts with its proprietary ultra-high-throughput screening platform. Serving the Feed & Food industries and chemical / biorefinery businesses, DIREVO products are developed either independently or in conjunction with global leaders such as Genencor (a division of Danisco A/S), AB Enzymes, Roal Ltd. and Nestlé. DIREVO Industrial Biotechnology GmbH is privately owned and located in Cologne, Germany. The shareholders include Wölbern EquityPartner GmbH (Hamburg), NRW Bank (Düsseldorf), TVM Capital (Munich), Danisco A/S (Copenhagen), a private equity firm affiliated with Sparkasse KölnBonn (Cologne), SandersMorrisHarris EnzymesLLC (New York), Mulligan BioCapital (Hamburg), and several private investors.

Wayport operates WiFi hotpots for partners since 1998 with key investors Seven Rosen Funds, New Enterprise Associates, Millennium Technology Ventures and Scale Venture Partners.

Valera is a specialty pharmaceutical company concentrating on the development, acquisition and commercialization of products for the treatment of urological and endocrine conditions, diseases and disorders, including products that utilize our proprietary technology.

- Jerini was founded in 1994 as a spin-off from the Medical Faculty (Charité) Humboldt University Berlin to commercialize the SPOT™ technology. The evolving SPOT™ platform was marketed as fee for service projects to pharmaceutical and biotech companies (1995 to 1999). The revenues generated supported the expansion of the company and its technology development. At this stage no venture capital was raised. Due to the expanding applications of its technology platform in drug discovery and proteomics Jerini began its transformation into a drug discovery company. - To support and accelerate the drug discovery transition Jerini raised Euro 4.6 million in January 2000 in a first financing round that included local investors IBB-Bet. GmbH, bmp AG and tbg. In 2001 the company converted to an AG (joint-stock company) and closed its second, private financing round raising Euro 20 million in November 2001. The investors in this round included an international group represented by TVM, 3i, Polytechnos and Sanders Morris and Harris. - In 2000 Jerini started creating the medicinal chemistry platform PepMed™ focusing on the identification of peptide lead structures addressing difficult protein targets and their subsequent systematic transformation into drug-like molecules. - In December 2001 Jerini started its first clinical trials with Icatibant, a peptidomimetic bradykinin receptor antagonist for the indication defined as end-stage liver cirrhosis.

IndX Software is an enterprise software company that designs and markets operations intelligence solutions for Fortune 2000 businesses (i.e., primarily process manufacturing) and their supply chains. The company’s product, XHQ, provides a single, coherent view of information that users need for real-time decision support or performance management, by extracting and integrating data from multiple, disparate back-end systems, aggregating and managing content, and distributing information to users. In 1999, Marwit led a $10 million equity investment in the Company.

Nuforia is an Internet professional services company resulting from the 1999 merger of communications.